Form D · Other Health Care
Allotera Therapeutics, Inc.
St. Louis, MO · CIK 0001874298
Offering snapshot reported Jul 23, 2026 · SEC filing
- Reported sold
- $123M Offering amount: $163M
- Investors reported
- 20 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 22, 2025 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$109,493,339 → $123,313,778
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 23, 2026 | Amendment | $123,313,778 | $13,820,439vs Sep 8, 2025 | 20 | SEC filing |
| Sep 8, 2025 | Initial | $109,493,339 | No comparison | 20 | SEC filing |
| Jul 23, 2021 | Initial | $37,233,405 | No comparison | 6 | SEC filing |
| Jul 23, 2021 | Initial | $98,500,011 | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-556954
Includes amounts receivable upon exercise of warrants to purchase shares of Series C Preferred Stock; such warrants have not yet been exercised.
Source: Form D, filed Jul 23, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Matthew Cooper | Executive |
| Jan K Davidson | Executive |
| Drew Dennison | Director |
| Bosun Hau | Director |
| Ayman Kabakibi | Executive |
| Daniel M Kemp | Director, Executive |
| Peter Kiener | Director |
| Kevin Li | Director |
| John P Mc Kearn | Director |
| Natalie Mount | Director |
| Bali Muralidhar | Director |
| Niall O'donnell | Director |
| Kumar Srinivasan | Director, Executive |
| Cherry Thomas | Executive |
| Keith Vendola | Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
4260 Forest Park Ave., Suite 100
St. Louis, MO, 63110
St. Louis, MO, 63110